512 results on '"Salami, Simpa"'
Search Results
2. Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response
3. A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: Considerations in PSA-based screening
4. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
5. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma
6. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men
7. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study.
8. Michigan Urology Academy—Our Role in Diversifying the Urology Workforce
9. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
10. Intra-practice Urologist-level Variation in Targeted Fusion Biopsy Outcomes
11. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
12. Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
13. Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
14. Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer
15. Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer
16. Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need
17. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature
18. PD16-04 SPATIAL ANALYSIS OF PRIMARY AND METASTATIC LESIONS IN SARCOMATOID RENAL CELL CARCINOMA REVEALS INSIGHT TO TUMOR BIOLOGY AND IMMUNE MICROENVIRONMENT
19. PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?
20. PD16-05 EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND PD-1/PD-L1 SIGNALING PROVIDE RECIPROCAL FEEDBACK IN RENAL CELL CARCINOMA PROGRESSION WITH IMPLICATIONS FOR IMMUNOTHERAPY RESPONSE
21. Prostate cancer clinical trial completion: The role of geography
22. Initial Findings from a High Genetic Risk Prostate Cancer Clinic
23. Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation
24. Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
25. Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer
26. Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.
27. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
28. A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer.
29. EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND PD-1/PD-L1 SIGNALING PROVIDE RECIPROCAL FEEDBACK IN RENAL CELL CARCINOMA PROGRESSION WITH IMPLICATIONS FOR IMMUNOTHERAPY RESPONSE
30. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA
31. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
32. Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
33. Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival
34. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer–specific Mortality: Competition Between Age and Time to Biochemical Failure
35. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen
36. Abstract PR014: Macrophage induced epithelial to mesenchymal transition in sarcomatoid renal cell carcinoma
37. Role of Adenosine Deaminase in Prostate Cancer Progression
38. Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice
39. Minimally Invasive Inguinal Lymphadenectomy in the Management of Penile Carcinoma
40. Association of transitional gradient from clear cell to sarcomatoid renal cell carcinoma with macrophage/tumor cell crosstalk.
41. Tumor size and genomic risk in localized prostate cancer
42. Surgical and Medical Options in the Management of Renal Cell Carcinoma
43. Editorial Comment
44. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
45. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy
46. Integrative multi-region molecular profiling of primary prostate cancer with synchronous lymph node metastasis to characterize the biologically dominant clone
47. Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate Cancer
48. Abstract 4700: Spatial analysis of the immune microenvironment and tumor cell transition in sarcomatoid renal cell carcinoma
49. MP17-11 REFINEMENT AND EXTERNAL VALIDATION OF A NOVEL MULTIPLEX URINE TEST FOR HIGH-GRADE PROSTATE CANCER
50. PD17-12 SPATIAL MOLECULAR IMAGING IN SARCOMATOID RENAL CELL CARCINOMA REVEALS CROSSTALK BETWEEN IMMUNE CELLS AND TUMOR CELLS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.